Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: Phase II study of indication and acceptance

Annals of Oncology

Volumn 25, Issue 6, 2014, Pages 1198-1203

  Daniëls, Laurien A ^a   Krol, A D G ^a   De Graaf, M A ^a,b   Scholte, A J H A ^a   Van't Veer, M B ^a   Putter, H ^a   de Roos, A ^a   Schalij, M J ^a   Creutzberg, C L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Coronary artery disease; CT coronary angiography; Hodgkin lymphoma; Late treatment effects; Screening

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVOR; CARDIAC IMAGING; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC IMAGING; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART MUSCLE REVASCULARIZATION; HODGKIN DISEASE; HUMAN; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; CLINICAL TRIAL; MEDIASTINUM; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; PREVALENCE; RADIATION RESPONSE; RADIOTHERAPY; SURVIVOR;

ADULT; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MEDIASTINUM; MIDDLE AGED; PREVALENCE; RADIOTHERAPY; SURVIVORS;

EID: 84903881154     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu130     Document Type: Article

References (20)

1. Ng AK, Bernardo MP, Weller E et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002; 20: 2101-2108.
2. Swerdlow AJ, Higgins CD, Smith P et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 2007; 99: 206-214.
3. Aleman BM, van den Belt-Dusebout AW, De Bruin ML et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007; 109: 1878-1886.
4. van Leeuwen-Segarceanu EM, Bos WJ, Dorresteijn LD et al. Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease. Cancer Treat Rev 2011; 37: 391-403.
5. von Ballmoos MW, Haring B, Juillerat P et al. Meta-analysis: diagnostic performance of low-radiation-dose coronary computed tomography angiography. Ann Intern Med 2011; 154: 413-420.
6. Kupeli S, Hazirolan T, Varan A et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. J Clin Oncol 2010; 28: 1025-1030.
7. Gibbons RJ, Balady GJ, Bricker JT et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 2002; 40: 1531-1540.
8. de Graaf FR, van Velzen JE, de Boer SM et al. Non-invasive computed tomography coronary angiography as a gatekeeper for invasive coronary angiography. Int J Cardiovasc Imaging 2013; 29: 221-228.
9. Abbara S, Arbab-Zadeh A, Callister TQ et al. SCCT guidelines for performance of coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr 2009; 3: 190-204.
10. Agatston AS, Janowitz WR, Hildner FJ et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832.
11. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
12. Arraras JI, Greimel E, Sezer O et al. An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients. Eur J Cancer 2010; 46: 2726-2738.
13. Michielsen HJ, De VJ, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale. J Psychosom Res 2003; 54: 345-352.
14. Choi EK, Choi SI, Rivera JJ et al. Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals. J Am Coll Cardiol 2008; 52: 357-365.
15. Cocks K, King MT, Velikova G et al. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 2011; 29: 89-96.
16. Wilson PW, D'Agostino RB et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
17. Rademaker J, Schoder H, Ariaratnam NS et al. Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. AJR Am J Roentgenol 2008; 191: 32-37.
18. Min JK, Shaw LJ, Devereux RB et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 2007; 50: 1161-1170.
19. Min JK, Berman DS, Dunning A et al. All-cause mortality benefit of coronary revascularization vs. medical therapy in patients without known coronary artery disease undergoing coronary computed tomographic angiography: results from CONFIRM (COronary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter Registry). Eur Heart J 2012; 33: 3088-3097.
20. Taylor HA, Deumite NJ, Chaitman BR et al. Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry. Circulation 1989; 79: 1171-1179.